Steven De Vleeschouwer Selected Research

Steven De Vleeschouwer Research Topics

Disease

33	Neoplasms (Cancer) 01/2024 - 05/2004
25	Glioblastoma (Glioblastoma Multiforme) 01/2024 - 09/2007
17	Glioma (Gliomas) 04/2022 - 05/2004
7	Brain Neoplasms (Brain Tumor) 06/2023 - 04/2011
2	Aneurysm (Aneurysms) 01/2022 - 02/2011
2	Melanoma (Melanoma, Malignant) 01/2017 - 09/2012
1	Inflammation (Inflammations) 01/2024
1	Cerebrospinal Fluid Leak 06/2022
1	Epilepsy (Aura) 04/2022
1	Thromboembolism 04/2022
1	Prolactinoma (Prolactinomas) 01/2022
1	Lymphoma (Lymphomas) 04/2021
1	Stroke (Strokes) 03/2021
1	Meningioma (Meningiomas) 03/2021
1	Headache (Headaches) 02/2021
1	Abscess 02/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 02/2021
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2017
1	Central Nervous System Neoplasms 04/2016
1	Hydrocephalus (Hydrocephaly) 03/2015
1	Infections 03/2015
1	Virus Diseases (Viral Diseases) 01/2015
1	Neoplasm Metastasis (Metastasis) 01/2012
1	Ependymoma 01/2012
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 02/2011
1	Edema (Dropsy) 05/2008

Drug/Important Bio-Agent (IBA)

8	VaccinesIBA 01/2024 - 05/2008
7	AntigensIBA 12/2023 - 04/2005
7	Galectin 1 (LGALS1)IBA 11/2023 - 04/2011
4	Temozolomide (Temodar)FDA LinkGeneric 06/2023 - 09/2010
3	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2017
3	ChemokinesIBA 12/2023 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 02/2016 - 04/2005
2	AntioxidantsIBA 01/2024 - 02/2016
2	Programmed Cell Death 1 ReceptorIBA 12/2023 - 01/2021
2	CytokinesIBA 01/2022 - 09/2007
2	RNA (Ribonucleic Acid)IBA 01/2021 - 10/2009
2	SuspensionsIBA 11/2017 - 04/2016
2	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 04/2016 - 09/2012
2	Galectins (Galectin)IBA 04/2016 - 09/2012
2	Polysaccharides (Glycans)IBA 02/2014 - 04/2011
2	Carrier Proteins (Binding Protein)IBA 02/2014 - 04/2011
1	Interferon Type IIBA 01/2024
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2024
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2023
1	gamma-glutamylaminomethylsulfonic acid (GAMS)IBA 11/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2023
1	AMG232IBA 05/2023
1	Complement System Proteins (Complement)IBA 05/2023
1	Indicators and Reagents (Reagents)IBA 04/2022
1	SteroidsIBA 04/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2021
1	Aminolevulinic Acid (Levulan)FDA Link 01/2020
1	AcidsIBA 01/2020
1	Blocking AntibodiesIBA 11/2017
1	Immune Checkpoint ProteinsIBA 11/2017
1	ChitosanIBA 04/2016
1	Small Interfering RNA (siRNA)IBA 04/2016
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 02/2016
1	CalreticulinIBA 03/2015
1	HMGB1 Protein (HMG1)IBA 03/2015
1	Therapeutic UsesIBA 03/2015
1	MicroRNAs (MicroRNA)IBA 02/2014
1	Messenger RNA (mRNA)IBA 09/2012
1	Neoplasm Antigens (Tumor Antigens)IBA 09/2007
1	InterferonsIBA 09/2007
1	Interleukin-10 (Interleukin 10)IBA 09/2007
1	InterleukinsIBA 09/2007
1	Fluorescein-5-isothiocyanate (FITC)IBA 04/2005

Therapy/Procedure

19	Immunotherapy 01/2024 - 01/2005
15	Therapeutics 12/2023 - 05/2004
6	Radiotherapy 12/2023 - 05/2004
6	Drug Therapy (Chemotherapy) 06/2023 - 09/2010
4	Chemoradiotherapy 01/2021 - 10/2009
2	Craniotomy 01/2022 - 02/2011
2	Combined Modality Therapy 04/2011 - 10/2009
1	Neurosurgical Procedures 06/2022
1	Stents 01/2022
1	Adjuvant Radiotherapy 03/2021
1	Lung Transplantation 02/2021
1	Transcranial Magnetic Stimulation 01/2019
1	Intranasal Administration 04/2016
1	Salvage Therapy 09/2015
1	Ventriculostomy 03/2015
1	Oncolytic Virotherapy 01/2015
1	Maintenance Chemotherapy 10/2009